[Skip to Navigation]
Sign In
Research Letter
May 20, 2021

Central Nervous System–Specific Outcomes of Phase 3 Randomized Clinical Trials in Patients With Advanced Breast Cancer, Lung Cancer, and Melanoma

Author Affiliations
  • 1Department of Medicine, University of Toronto, Toronto, Ontario, Canada
  • 2Faculty of Medicine, McMaster University, Hamilton, Canada
  • 3Department of Oncology, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, Canada
  • 4Division of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston
  • 5Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston
  • 6Division of Neurosurgery, St Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada
  • 7Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada
  • 8Division of Medical Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada
JAMA Oncol. 2021;7(7):1062-1064. doi:10.1001/jamaoncol.2021.1359
Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×